STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $285,000 | -62.2% | 26,819 | -45.5% | 0.01% | -67.4% |
| Q2 2019 | $753,000 | +370.6% | 49,172 | +294.3% | 0.04% | +330.0% |
| Q1 2019 | $160,000 | -55.1% | 12,472 | -42.0% | 0.01% | -37.5% |
| Q3 2018 | $356,000 | -27.5% | 21,497 | -29.8% | 0.02% | -20.0% |
| Q2 2018 | $491,000 | +208.8% | 30,628 | +199.2% | 0.02% | +185.7% |
| Q4 2017 | $159,000 | -10.7% | 10,238 | -36.2% | 0.01% | -22.2% |
| Q3 2017 | $178,000 | -4.8% | 16,038 | -21.1% | 0.01% | -10.0% |
| Q2 2017 | $187,000 | -37.5% | 20,338 | -42.0% | 0.01% | -28.6% |
| Q1 2017 | $299,000 | +269.1% | 35,038 | +190.5% | 0.01% | +250.0% |
| Q2 2016 | $81,000 | -20.6% | 12,061 | -25.8% | 0.00% | -20.0% |
| Q4 2015 | $102,000 | -46.6% | 16,261 | -25.0% | 0.01% | -28.6% |
| Q3 2015 | $191,000 | -50.3% | 21,679 | -33.6% | 0.01% | -46.2% |
| Q2 2015 | $384,000 | -20.2% | 32,655 | +61.8% | 0.01% | -18.8% |
| Q2 2013 | $481,000 | – | 20,184 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |